112 related articles for article (PubMed ID: 1526872)
1. Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography.
Roberson PL; Buchsbaum DJ; Heidorn DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 1992; 24(2):329-34. PubMed ID: 1526872
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
3. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography.
Muthuswamy MS; Roberson PL; Ten Haken RK; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):165-72. PubMed ID: 8641915
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft model.
Roberson PL; Dudek S; Buchsbaum DJ
Cancer; 1997 Dec; 80(12 Suppl):2567-75. PubMed ID: 9406711
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
Buchsbaum DJ; Lawrence TS; Roberson PL; Heidorn DB; Ten Haken RK; Steplewski Z
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):629-38. PubMed ID: 8454481
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
Roberson PL; Yokoyama S; Rogers BE; Buchsbaum DJ
Cancer Biother Radiopharm; 2003 Apr; 18(2):239-47. PubMed ID: 12804050
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose-rate nonuniformity.
Roberson PL; Heidorn DB; Kessler ML; Ten Haken RK; Buchsbaum DJ
Cancer; 1994 Feb; 73(3 Suppl):912-8. PubMed ID: 8306279
[TBL] [Abstract][Full Text] [Related]
8. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611
[TBL] [Abstract][Full Text] [Related]
9. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
10. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
Roberson PL; Buchsbaum DJ
Cancer Res; 1995 Dec; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
[TBL] [Abstract][Full Text] [Related]
11. Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts.
Buras RR; Wong JY; Kuhn JA; Beatty BG; Williams LE; Wanek PM; Beatty JD
Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):473-9. PubMed ID: 8436526
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
Buchsbaum DJ; ten Haken RK; Heidorn DB; Lawrence TS; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z; Lichter AS
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1033-41. PubMed ID: 2347713
[TBL] [Abstract][Full Text] [Related]
13. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
Goel A; Augustine S; Baranowska-Kortylewicz J; Colcher D; Booth BJ; Pavlinkova G; Tempero M; Batra SK
Clin Cancer Res; 2001 Jan; 7(1):175-84. PubMed ID: 11205906
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
[TBL] [Abstract][Full Text] [Related]
15. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
16. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
17. Autoradiography-based, three-dimensional calculation of dose rate for murine, human-tumor xenografts.
Koral KF; Kwok CS; Yang FE; Brown RS; Sisson JC; Wahl RL
Nucl Med Biol; 1993 Nov; 20(8):901-9. PubMed ID: 8298569
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
[TBL] [Abstract][Full Text] [Related]
19. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
[TBL] [Abstract][Full Text] [Related]
20. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
Stein R; Goldenberg DM; Thorpe SR; Mattes MJ
J Nucl Med; 1997 Mar; 38(3):391-5. PubMed ID: 9074526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
